Cord Blood Infusion for Ischemic Stroke


Phase 1 Results N/A

Summary of Purpose

This is a phase one study investigating the safety of a single, intravenous infusion of banked allogeneic umbilical cord blood in subjects following an acute ischemic stroke. The cord blood infusion must be given within 3-10 days of the stroke. Follow up phone calls will occur at 1, 6, and 12 months post-infusion, and will include telephone surveys on post-stroke rehabilitation and functioning. A follow up clinic...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 March 2017.

1 May 2015 19 Mar 2015 23 Feb 2017 23 Feb 2017 1 Mar 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment